140 related articles for article (PubMed ID: 6218118)
1. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
Dzierzanowska D; Patzer J; Jeljaszewicz J
Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
[TBL] [Abstract][Full Text] [Related]
2. [Studies with azlocillin, mezlocillin, penicillin-g-potassium and sisomicin on tolerance in the cornea and the kinetics of inhibiting concentrations in the cornea and aqueous humor in rabbits].
Gauri KK; Finck J; Claussen B; Schassan HH; Fedder J; Weuta H
Infection; 1982; 10 Suppl 3():S221-6. PubMed ID: 6218119
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
Dzierzanowska D; Jeljaszewicz J
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
[TBL] [Abstract][Full Text] [Related]
5. [Transperitoneal resorption of oxacillin, azlocillin and sisomicin in continuous ambulatory peritoneal dialysis in patients with and without peritonitis].
Thomae U; Boos W; Adam D
Med Welt; 1981 Sep; 32(37):1365-7. PubMed ID: 7300642
[No Abstract] [Full Text] [Related]
6. The combined action of azlocillin and sisomicin in a model simulating the in vivo serum kinetics.
Haller I
Infection; 1983; 11 Suppl 2():S81-2. PubMed ID: 6423547
[TBL] [Abstract][Full Text] [Related]
7. Interactions between mezlocillin and sisomicin in vitro and in patients with normal and various degrees of impaired renal function.
Kampf D; Schurig R; Bergs A; Förster D
Clin Nephrol; 1983 Jan; 19(1):37-44. PubMed ID: 6219847
[TBL] [Abstract][Full Text] [Related]
8. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
Lode H; Niestrath U; Koeppe P; Langmaack H
Infection; 1977; 5(3):163-9. PubMed ID: 334673
[TBL] [Abstract][Full Text] [Related]
9. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
Weingärtner L; Sitka U; Patsch R; Thiemann HH
Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
[TBL] [Abstract][Full Text] [Related]
10. Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.
Haller I
Infection; 1982; 10 Suppl 3():S229-33. PubMed ID: 6818155
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
Bergan T; Thorsteinsson SB; Steingrimsson O
Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
[TBL] [Abstract][Full Text] [Related]
12. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
Gundert-Remy U; Weber E
Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
[TBL] [Abstract][Full Text] [Related]
13. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
Haen E; Remien J; Richter E; Frank U; Adam D
Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
[TBL] [Abstract][Full Text] [Related]
14. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
[No Abstract] [Full Text] [Related]
15. [In vitro effect of acylureido penicillins and mezlocillin on anaerobic sporeless gram-negative rods of genus Bacteroides].
Höhne C
Infection; 1982; 10 Suppl 3():S238-43. PubMed ID: 6218120
[TBL] [Abstract][Full Text] [Related]
16. [Decrease of sisomicin nephrotoxicity as affected by cephalothin: pharmacokinetic evaluation].
Gagaeva EV; Firsov AA; Egorenko GG; Berezina EK; Shtegel'man LA
Antibiot Med Biotekhnol; 1985 Mar; 30(3):190-6. PubMed ID: 4015061
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
Wittmann DH; Schassan HH; Seidel H
Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin.
Lode H; Kemmerich B; Koeppe P
Antimicrob Agents Chemother; 1975 Oct; 8(4):396-401. PubMed ID: 1103722
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of sisomicin in humans.
Chung M; Schrogie JJ; Symchowicz S
J Pharmacokinet Biopharm; 1981 Oct; 9(5):535-51. PubMed ID: 7334458
[TBL] [Abstract][Full Text] [Related]
20. Excretion of azlocillin and mezlocillin by the normal pancreas and in acute pancreatitis in dogs and rats.
Demol P; Singer MV; Bernemann D; Linzenmeier G; Goebell H
Digestion; 1983; 27(2):93-9. PubMed ID: 6628842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
